US Digestive Health, Takeda & more: 4 GI company key notes

Here are four updates from gastroenterology companies from the past week:

Advertisement

Amulet Capital Partners closed the fourth private equity investment in GI June 6 when it formed US Digestive Health, a gastrointestinal-focused practice management organization. Read more. 

SeekingAlpha analyzed CRH Medical, offering insights into the company’s recent history and predictions on its future.

The FDA granted Motus GI 510(k) approval for Pure-Vu Gen 2, the newest iteration of its colonoscopy preparation system.

Uthra Sundaram, senior vice president of Takeda’s gastrointestinal business unit, shared insights into the company’s focus on GI, its drug pipeline and how the company’s acquisition of Shire has been received. Read more.

More articles on gastroenterology:
EyePoint Pharmaceuticals adds 2 executives
ASC supply chain tip of the day: Track trends
IU Health distribution center plans to deliver to ASCs

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.